Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
Medicines Co.
WKN: 938858 / Symbol: MDCO / Name: Medicines / Aktie / Pharmazeutika / Mid Cap /
76,00 €
-
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
Johnson & Johnson (NYSE: JNJ) is one of the world's largest healthcare companies, with a diverse product portfolio that includes pharmaceuticals, medical devices and consumer health products
Der Beitrag wird untersucht



Neueste Beiträge
MaxHolloway in WD-40 Company Justifies Sell-Side Support With Q2 Results